Pfizer cuts 330 jobs in Italy as JPMorgan lifts target for Pfizer stock - ad-hoc-news.de
Article excerpt
Highlighted: the sentence this signal was extracted from
Pfizer Inc. (ISIN US7170811035) was trading at EUR 25.59 at Lang & Schwarz on October 13, 2026 at 11:55 a.m. CEST, up 0.63 percent versus the Xetra close of EUR 25.43 on October 12, 2026. The company planned to cut 330 jobs at its Catania plant in Italy, while JPMorgan raised its Pfizer price target from USD 28.00 to USD 30.00 between October 6 and October 9, 2026, according to Yahoo Finance . On October 2, 2026, Yahoo Finance published Pfizer's second-quarter 2026 earnings-call transcript, which reported USD 15.03 billion in revenue and adjusted diluted earnings per share of USD 0.77. On October 8, 2026, Cantor Fitzgerald lifted its price target from USD 27.00 to USD 28.00, as reported by MarketBeat. On October 12, 2026, Barchart reported the planned 330 job cuts and the closure of the plant's penicillin department. Pfizer's second-quarter revenue rose 2.6 percent year over year to USD 15.03 billion, while adjusted diluted earnings per share declined from USD 0.78 to USD 0.77, according to Yahoo Finance. Pfizer raised its full-year 2026 revenue outlook by USD 500 million at the midpoint to USD 60.50 billion-USD 62.50 billion from USD 59.50 billion-USD 60.50 billion, while retaining adjusted diluted earnings-per-share guidance of USD 2.80-USD 3.00. The operating picture is mixed. Launched and acquired products grew 18 percent operationally in the second quarter of 2026...
Keep reading with a free account
The rest of this article, and every signal for Pfizer, is in your free account.
